09/24/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 9/24/2020. This four-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the COViage System (or “COViage”) for use by healthcare providers in the hospital setting for adult patients (18 years of age or older who are admitted to the hospital) with confirmed COVID-19 (based on a positive PCR test result) for the computation of proprietary patient status indices referred to as Respiratory Decompensation Status and Hemodynamic Instability Status as an adjunct to patient monitoring during the COVID-19 outbreak. (PDF)
No hay comentarios:
Publicar un comentario